February, 2017

Zafgen to Present at Upcoming Investor Conferences

BOSTON, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated ...

TESARO Announces Fourth-Quarter 2016 Operating Results

Niraparib NDA under review by FDA; pre-launch preparations for planned commercial launch well underwayExpanded ...

Zafgen to Present at Upcoming Investor Conferences

BOSTON, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated ...

MacroGenics Provides Update on Corporate Progress and 2016 Financial Results

ROCKVILLE, Md., Feb. 28, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical ...

MacroGenics Provides Update on Corporate Progress and 2016 Financial Results

ROCKVILLE, Md., Feb. 28, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical ...

Palliative care ‘in my hands’

A randomized controlled multicenter study published by Carson et al. in JAMA concluded that, ...

Vascular surgeons underutilize palliative care planning

FROM JAMA SURGERY Investment in advanced palliative care planning has the potential to improve ...

[sam_pro id=0_12 codes="true"]
[sam_pro id=0_6 codes="false"]